Company / Current Liabilities per Share
Editas Medicine, Inc. Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.56
FY2025
5-year range
$0.56 / $0.94
FY2021-FY2025
Trend
-40.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 8 years, ranging from $0.56 in FY2025 to $1.23 in FY2019.
Based on SEC 10-K filings.
0.56 in FY2025 with a 5-year CAGR of -12.2%.
Improved from $0.92 to $0.56 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -14.0%
- 5-Year CAGR
- -12.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 40.8% year-over-year.
- Peak current liabilities per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.56 | -40.8% |
| FY2024 | $0.94 | +2.9% |
| FY2023 | $0.92 | +4.5% |
| FY2022 | $0.88 | +17.2% |
| FY2021 | $0.75 | -30.0% |
| FY2020 | $1.07 | -12.9% |
| FY2019 | $1.23 | +52.5% |
| FY2018 | $0.81 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026